McKesson Corporation $MCK Stock Purchased by Nisa Investment Advisors LLC

Key Points

• Nisa Investment Advisors increased its McKesson stake by 14.5% in the third quarter, bringing its holdings to 49,011 shares valued at approximately $41.9 million. Institutional investors and hedge funds collectively own 85.07% of the stock.
• McKesson exceeded quarterly expectations with $9.93 EPS and $105.38 billion in revenue, while revenue grew 7.7% year over year. Management guided to fiscal 2027 EPS of $44.20–$45.00.
• Analyst sentiment remains favorable, with 15 Buy ratings and four Holds and an average price target of $997.12; however, the stock was trading near its 52-week high, and recent insider sales were conducted under pre-arranged trading plans.

Nisa Investment Advisors LLC raised its holdings in shares of McKesson Corporation (NYSE:MCK - Free Report) by 14.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 49,011 shares of the company's stock after purchasing an additional 6,190 shares during the period. Nisa Investment Advisors LLC's holdings in McKesson were worth $41,891,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. Secure Asset Management LLC raised its position in shares of McKesson by 484.8% during the 2nd quarter. Secure Asset Management LLC now owns 2,123 shares of the company's stock valued at $1,604,000 after acquiring an additional 1,760 shares during the last quarter. Royal London Asset Management Ltd. lifted its stake in shares of McKesson by 1.1% in the 2nd quarter. Royal London Asset Management Ltd. now owns 112,241 shares of the company's stock valued at $84,809,000 after purchasing an additional 1,216 shares during the period. Benchmark Investment Advisors LLC acquired a new position in shares of McKesson in the 2nd quarter valued at $441,000. Summit Global Investments acquired a new position in shares of McKesson in the 2nd quarter valued at $1,159,000. Finally, One Wealth Advisors LLC bought a new position in shares of McKesson in the 2nd quarter worth $1,494,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

McKesson News Summary

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: UBS raised its price target to $1,200, implying additional upside and reinforcing the bullish view on McKesson’s pharmaceutical distribution and healthcare-services businesses. UBS raises target for McKesson stock
• Positive Sentiment: Leerink raised its target from $1,030 to $1,070, adding to a series of upward revisions from analysts. Leerink raises McKesson price target
• Positive Sentiment: McKesson recently reported quarterly earnings and revenue above consensus estimates. EPS was $9.93 versus $9.56 expected, while revenue reached $105.38 billion, up 7.7% year over year. Management’s fiscal 2027 EPS guidance of $44.20–$45.00 also supports the growth narrative. McKesson outperforms broader market
• Neutral Sentiment: Mizuho lifted its price target from $905 to $1,020 but maintained a “neutral” rating. The revised target is close to, but below, the current market valuation, suggesting limited near-term upside in that analyst’s view. Mizuho adjusts McKesson price target
• Negative Sentiment: Executive Vice President Francisco Fraga sold 800 shares worth approximately $796,640. However, the transaction was conducted under a pre-arranged Rule 10b5-1 plan, reducing its significance as a discretionary bearish signal. McKesson executive stock sale

McKesson Price Performance

McKesson stock opened at $1,029.52 on Wednesday. The firm has a market capitalization of $120.03 billion, a price-to-earnings ratio of 27.55, a PEG ratio of 2.01 and a beta of 0.30. The company's 50 day simple moving average is $902.90 and its 200 day simple moving average is $839.47. McKesson Corporation has a fifty-two week low of $723.68 and a fifty-two week high of $1,030.27.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, beating the consensus estimate of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The firm had revenue of $105.38 billion during the quarter, compared to the consensus estimate of $103.88 billion. During the same quarter in the prior year, the firm earned $8.26 earnings per share. The business's quarterly revenue was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, analysts predict that McKesson Corporation will post 44.71 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on MCK. Wall Street Zen raised McKesson from a "hold" rating to a "buy" rating in a research note on Saturday. Mizuho upped their price objective on McKesson from $905.00 to $1,020.00 and gave the company a "neutral" rating in a report on Tuesday. Weiss Ratings upgraded McKesson from a "buy (b-)" rating to a "buy (b)" rating in a report on Friday, September 4th. Wells Fargo & Company increased their target price on McKesson from $812.00 to $933.00 and gave the company an "equal weight" rating in a research note on Tuesday, August 11th. Finally, Leerink Partners raised their target price on McKesson from $1,030.00 to $1,070.00 and gave the stock an "outperform" rating in a report on Wednesday, October 7th. Fifteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, McKesson has an average rating of "Moderate Buy" and an average price target of $997.12.

Insider Transactions at McKesson

In related news, EVP Francisco Fraga sold 800 shares of the company's stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $995.80, for a total value of $796,640.00. Following the completion of the sale, the executive vice president owned 5,423 shares in the company, valued at $5,400,223.40. This represents a 12.86% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the company's stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total transaction of $98,950.95. Following the completion of the sale, the chief accounting officer owned 521 shares of the company's stock, valued at approximately $464,445.45. This represents a 17.56% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,212 shares of company stock valued at $1,164,182 over the last three months. 0.06% of the stock is currently owned by corporate insiders.

McKesson Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson's principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.